The efficacy and safety of Health Qigong for ankylosing spondylitis: Protocol for a systematic review and meta-analysis.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
4
2
2020
pubmed:
6
2
2020
medline:
19
2
2020
Statut:
ppublish
Résumé
Non-pharmacological treatments (education, exercise, and physical therapy) are remain basic approaches to long-term management of ankylosing spondylitis (AS) patients. As an important part of non-pharmacological treatments, Health Qigong is widely used for AS treatment. We will perform the systematic review to confirm the safety and efficacy of Health Qigong for AS. Systematical search of 6 electronic databases will be done, including English and Chinese, until December 2019. All randomized controlled trials (RCTs) involving Health Qigong in combination with conventional therapy for AS will be included. Study selection, data extraction, and validation were performed independently by 2 reviewers. RevMan (V.5.3) will be used for mata-analysis. This systematic review will identify the safety and efficacy of Health Qigong in the treatment of AS and update evidence summaries of Health Qigong. At the end of the treatment, the primary outcome is Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) with a range of 0 to 10,and the secondary outcomes will include functional ability that measured by Bath Ankylosing Spondylitis Functional Index (BASFI), mobility measured by Bath Ankylosing Spondylitis Metrology Index (BASMI), chest expansion, night spinal pain, adverse reactions, laboratory measures such as erythrocyte sedimentation rate (ESR) and C protein response (CRP). This study will provide evidence that whether Health Qigong can benefit patients with ankylosing spondylitis by reducing disease activity, alleviating pain to support the application of Health Qigong in the AS treatment. CRD42019159126.
Sections du résumé
BACKGROUND
BACKGROUND
Non-pharmacological treatments (education, exercise, and physical therapy) are remain basic approaches to long-term management of ankylosing spondylitis (AS) patients. As an important part of non-pharmacological treatments, Health Qigong is widely used for AS treatment. We will perform the systematic review to confirm the safety and efficacy of Health Qigong for AS.
METHODS
METHODS
Systematical search of 6 electronic databases will be done, including English and Chinese, until December 2019. All randomized controlled trials (RCTs) involving Health Qigong in combination with conventional therapy for AS will be included. Study selection, data extraction, and validation were performed independently by 2 reviewers. RevMan (V.5.3) will be used for mata-analysis.
RESULTS
RESULTS
This systematic review will identify the safety and efficacy of Health Qigong in the treatment of AS and update evidence summaries of Health Qigong. At the end of the treatment, the primary outcome is Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) with a range of 0 to 10,and the secondary outcomes will include functional ability that measured by Bath Ankylosing Spondylitis Functional Index (BASFI), mobility measured by Bath Ankylosing Spondylitis Metrology Index (BASMI), chest expansion, night spinal pain, adverse reactions, laboratory measures such as erythrocyte sedimentation rate (ESR) and C protein response (CRP).
CONCLUSION
CONCLUSIONS
This study will provide evidence that whether Health Qigong can benefit patients with ankylosing spondylitis by reducing disease activity, alleviating pain to support the application of Health Qigong in the AS treatment.
REGISTRATION NUMBER
BACKGROUND
CRD42019159126.
Identifiants
pubmed: 32011452
doi: 10.1097/MD.0000000000018734
pii: 00005792-202001170-00023
pmc: PMC7220104
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e18734Références
BMC Public Health. 2019 Nov 8;19(1):1488
pubmed: 31703654
Reumatismo. 2010 Jan-Mar;62(1):4-11
pubmed: 20390114
Forsch Komplementmed. 2015;22(6):395-402
pubmed: 26840422
Curr Rheumatol Rep. 2019 Nov 16;21(11):59
pubmed: 31734867
Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii8-18
pubmed: 12381506
Complement Ther Med. 2019 Apr;43:109-116
pubmed: 30935517
Medicine (Baltimore). 2019 Oct;98(42):e17509
pubmed: 31626108
Rheumatology (Oxford). 2018 Aug 1;57(suppl_6):vi4-vi9
pubmed: 30445483
Oncol Res Treat. 2019;42(9):431-439
pubmed: 31266043
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S47-58
pubmed: 22588768
Zhongguo Zhen Jiu. 2016 Aug 12;36(8):893-896
pubmed: 29231581
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
N Engl J Med. 2016 Sep 29;375(13):1302-3
pubmed: 27682052
Rheumatol Int. 2014 Nov;34(11):1505-11
pubmed: 24626605
Front Immunol. 2018 Nov 16;9:2668
pubmed: 30505307
Lancet. 2007 Apr 21;369(9570):1379-1390
pubmed: 17448825
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Complement Ther Clin Pract. 2019 Aug;36:113-119
pubmed: 31383427
Eur J Phys Rehabil Med. 2009 Dec;45(4):449-57
pubmed: 20032902
Curr Rheumatol Rev. 2020;16(4):311-318
pubmed: 31656154
Rheumatology (Oxford). 2020 Jul 1;59(7):1679-1683
pubmed: 31670801
Lancet. 2017 Jul 1;390(10089):73-84
pubmed: 28110981
Bone Res. 2019 Aug 5;7:22
pubmed: 31666997
F1000Res. 2018 Sep 21;7:
pubmed: 30345001
Rheumatology (Oxford). 2014 Apr;53(4):650-7
pubmed: 24324212
JAMA Intern Med. 2018 Oct 1;178(10):1301-1310
pubmed: 30208396
J Alzheimers Dis. 2017;60(2):389-400
pubmed: 28869478
Curr Allergy Asthma Rep. 2015 Jan;15(1):489
pubmed: 25447326